Skip to content

Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID

CompletedNot applicableNCT06476496
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this preliminary study is to test methods and procedures to be used in a fully-powered trial to evaluate acupuncture treatment effectiveness. Specifically, we will test the feasibility of conducting a 2-arm randomized clinical trial for evaluating the effectiveness of acupuncture for pain in patients with long COVID. Researchers will compare pain intensity and impact on general activities over 5 months in those who receive acupuncture treatment compared to patients who are receiving usual long COVID care. Participants will complete 4 online surveys at weeks 0, 4, 8, and 20. These surveys include validated mental and physical health questionnaires. Participants who are randomly selected to receive the intervention will receive 8 acupuncture treatment sessions.

Study details

Official title
Pain Relief With Integrative Medicine (PRIMe)?: Feasibility of Acupuncture for Long COVID
Conditions
Sponsor
University of Washington
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Start date
2024-06-21
Primary completion
2025-03-30
Sex
All
Age range
from 18 Years
Healthy volunteers
true
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ≥ 18 years of age at the time of consent. * Previous suspected, probable, or confirmed SARS-CoV-2 infection, as defined by the Pan American Health Organization * Report pain symptoms including musculoskeletal pain (joint, muscle, bone pain), chest pain, abdominal pain, headache, back pain, nerve pain, and pain in ear following a SARS-CoV-2 infection that has persisted for at least 12 weeks and is still present at the time of consent. * Report pain intensity (0-10 scale) ≥4 in the last 7 days.28 * As of today, has been seen by a clinician in the UW Long COVID Clinic either in-person or via telehealth/virtual visit * Able to speak and read English and provide informed consent to complete the study requirements. Exclusion Criteria: * \<18 years of age at the time of consent. * Reports absence of pain, pain for less than 12 weeks, or a pain intensity \<4 over the last 7 days. * Report baseline level of pain for those who have pre-existing chronic pain (i.e., chronic pain condition(s) present prior to COVID-19 illness AND chronic pain not worsened post-COVID). * Already received acupuncture treatment for long COVID symptoms. * Unable to travel to the UW Northgate Clinic once a week for 8 weeks for acupuncture treatments. * Has seizure disorder with high risk of seizure (i.e., new diagnosis of seizure disorder and/or new medication in the last 3 months, or uncontrolled/unclear triggers for seizures). * Is currently Pregnant * Is receiving active cancer therapy * Has severe neutropenia (\<500 WBC) due to any cause within the last 6 months

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06476496